Cargando…

Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis

We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-pri...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Hara, Maureen, Zhou, Xing (Alex)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759631/
https://www.ncbi.nlm.nih.gov/pubmed/36568646
http://dx.doi.org/10.1016/j.jfineco.2021.05.052
_version_ 1784852274140413952
author O'Hara, Maureen
Zhou, Xing (Alex)
author_facet O'Hara, Maureen
Zhou, Xing (Alex)
author_sort O'Hara, Maureen
collection PubMed
description We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-primary dealers, shifted from buying to selling, causing dealers’ inventories to plummet. Liquidity provisions in electronic customer-to-customer trading increased, though at prohibitively high costs. By improving dealer funding conditions and providing a liquidity backstop, the Primary Dealer Credit Facility and the Secondary Market Corporate Credit Facility (SMCCF) stabilized trading conditions. Most of the impact of SMCCF on bond liquidity seems to have materialized following its announcement. We argue that the Federal Reserve's actions reflect a new role as market maker of last resort.
format Online
Article
Text
id pubmed-9759631
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-97596312022-12-19 Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis O'Hara, Maureen Zhou, Xing (Alex) J financ econ Article We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-primary dealers, shifted from buying to selling, causing dealers’ inventories to plummet. Liquidity provisions in electronic customer-to-customer trading increased, though at prohibitively high costs. By improving dealer funding conditions and providing a liquidity backstop, the Primary Dealer Credit Facility and the Secondary Market Corporate Credit Facility (SMCCF) stabilized trading conditions. Most of the impact of SMCCF on bond liquidity seems to have materialized following its announcement. We argue that the Federal Reserve's actions reflect a new role as market maker of last resort. Elsevier B.V. 2021-10 2021-06-01 /pmc/articles/PMC9759631/ /pubmed/36568646 http://dx.doi.org/10.1016/j.jfineco.2021.05.052 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
O'Hara, Maureen
Zhou, Xing (Alex)
Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title_full Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title_fullStr Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title_full_unstemmed Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title_short Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
title_sort anatomy of a liquidity crisis: corporate bonds in the covid-19 crisis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759631/
https://www.ncbi.nlm.nih.gov/pubmed/36568646
http://dx.doi.org/10.1016/j.jfineco.2021.05.052
work_keys_str_mv AT oharamaureen anatomyofaliquiditycrisiscorporatebondsinthecovid19crisis
AT zhouxingalex anatomyofaliquiditycrisiscorporatebondsinthecovid19crisis